You've been vaccinated; can you now safely see your friends and family? New research hints that vaccinated people may be less likely to transmit the coronavirus, but they are not 100% in the clear.
Academic rigour, journalistic flair
Articles on SARS-CoV-2
Displaying 1 - 20 of 327 articles
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to global vaccination efforts.
Much has been said of the politics surrounding the mission to investigate the viral origins of COVID-19. So it's easy to forget that behind these investigations are real people.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
'Long COVID' – in which people have symptoms lasting more than a few weeks – is turning out to be very common. People hospitalized for COVID-19 are at highest risk, but they aren't alone.
The Oxford/AstraZeneca vaccine is the second COVID shot to be approved in Australia, and it's likely Australians will start receiving it next month.
The rapid increase in the number of infections is the most obvious reason why new variants of the virus have been emerging recently. Case numbers doubled in just two months at the end of 2020.
Even those that live in areas where the population has already been vaccinated would not be totally protected if the virus mutates elsewhere.
In the context of COVID-19, we're hearing about new mutations, strains and variants all the time. It's no wonder it can all get a bit confusing.
Never has the saying 'dynamite comes in small packages' been more apt.
These variants are definitely cause for concern. But there's every indication we can adapt our vaccine strategy to combat these and other variants going forward.
Masks between 7am and 9am for those born before 2005 – Sweden's coronavirus policies are unnecessarily confusing.
A bat virus discovered a decade ago in Cambodia indicates that pangolin trafficking remains a credible explanation for the origin of the Covid-19 pandemic.
Everything you need to know about fit, filtration and breathability.
The virus is evolving and new strains are more transmissible. Will the vaccines work against these new variants? How can researchers stay ahead of the virus's evolution?
Recently announced travel restrictions are intended to curb the spread of COVID-19 variants. However, we need to do a better job of tracking arrivals into the country.
Getting pharmacies more involved could be a game changer, particularly for reaching minorities, older adults without internet access and others left behind.
Ever since the 2001 SARS outbreak and H5N1 avian flu in 2003, we’ve developed tools to monitor diseases that transmitted from animals to humans. But what does a large-scale roll-out entail?
With slow vaccine distribution and manufacturing, some people won't get the second dose on time. But does it matter?
Jackson Mthembu's death drives home the seriousness of the COVID-19 pandemic in the country.
Job Board
-
Solutions Consultant
-
Digital Editor at The Conversation AU, 8 month contract
-
ARC Grant-Funded Researcher A - School of Mathematical Sciences
-
PLACEMENT OFFICER
-
Committee Member - MNF Research Advisory Committee
Top contributors
-
Professor of Medicine, University of Virginia
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Associate Professor, La Trobe University
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW
-
NHMRC early career fellow, The Peter Doherty Institute for Infection and Immunity
-
Professor of Vaccinology and Director of the SAMRC Vaccines and Infectious Diseases Analytical Research Unit, University of the Witwatersrand
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County
-
Professor of Immunology, RMIT University
-
Matthew Woodruff is a Friend of The Conversation.
Instructor, Lowance Center for Human Immunology, Emory University
-
Cameron Webb is a Friend of The Conversation.
Clinical Associate Professor and Principal Hospital Scientist, University of Sydney
-
Research Fellow, Virology, Queen's University Belfast
